Topics: Single Cells (GEX/ATAC/ADT/Multiome…)
Origin: IP
Project type: Expertise
Name of Applicant: Slobodan Culina
Date of application: 26-06-2024
Unit: Single Cell Platform
Location: 27-01-08a
Phone: 01 76 53 54 43
@ Mail: slobodan.culina@pasteur.fr
@ PI-Mail: milena.hasan@pasteur.fr
Project context and summary: The cell immunotherapy is expected to induce a host immune response against cancer cells. The study is designed to assess the immune response (particularly T cells) in treated participants. In addition, the process will be validated on non-treated healthy participants in a pilot study.
Related team publications:Manager: marc.monot@pasteur.frStatus: Closed